Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Tabula Rasa HealthCare stock (TRHC)

Buy Tabula Rasa HealthCare stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Tabula Rasa HealthCare is a health information services business based in the US. Tabula Rasa HealthCare shares (TRHC) are listed on the NASDAQ and all prices are listed in US Dollars. Tabula Rasa HealthCare employs 1,027 staff and has a trailing 12-month revenue of around $338.1 million.

Our top picks for where to buy Tabula Rasa HealthCare stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Tabula Rasa HealthCare stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – TRHC. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Tabula Rasa HealthCare stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Moomoo
Finder Score: 4.3 / 5: ★★★★★
Exclusive
Moomoo
★★★★★
Stocks, Options, ETFs
$0
$0
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Public.com
Finder Score: 4.2 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
5.1%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Tabula Rasa HealthCare stock price (NASDAQ: TRHC)

Use our graph to track the performance of TRHC stocks over time.

Tabula Rasa HealthCare shares at a glance

Information last updated 2024-06-30.
Latest market close$0.00
52-week range$7.50 - $10.50
50-day moving average $10.36
200-day moving average $7.69
Wall St. target price$10.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.46

Is it a good time to buy Tabula Rasa HealthCare stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tabula Rasa HealthCare price performance over time

Historical closes compared with the close of $0 from 2023-11-16

1 week (2024-07-15) nan%
1 month (2024-06-22) nan%
3 months (2024-04-22) nan%
6 months (2024-01-22) nan%
1 year (2023-07-26) -100.00%
2 years (2022-07-26) -100.00%
3 years (2021-07-26) 41.28
5 years (2019-07-26) 57.55

Is Tabula Rasa HealthCare stock undervalued or overvalued?

Valuing Tabula Rasa HealthCare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tabula Rasa HealthCare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Tabula Rasa HealthCare's PEG ratio

Tabula Rasa HealthCare's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 7.2944. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Tabula Rasa HealthCare's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Tabula Rasa HealthCare financials

Revenue TTM $338.1 million
Gross profit TTM $66.9 million
Return on assets TTM -5.98%
Return on equity TTM -555.2%
Profit margin -28.23%
Book value $-3.05
Market Capitalization $284 million

TTM: trailing 12 months

Tabula Rasa HealthCare share dividends

We're not expecting Tabula Rasa HealthCare to pay a dividend over the next 12 months.

Tabula Rasa HealthCare share price volatility

Over the last 12 months, Tabula Rasa HealthCare's shares have ranged in value from as little as $7.5 up to $10.5. A popular way to gauge a stock's volatility is its "beta".

TRHC.US volatility(beta: 1.57)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tabula Rasa HealthCare's is 1.57. This would suggest that Tabula Rasa HealthCare's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Tabula Rasa HealthCare overview

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third-party administrator services. As of December 31, 2022, it served approximately 150 healthcare organizations.

Frequently asked questions

What percentage of Tabula Rasa HealthCare is owned by insiders or institutions?
Currently 12.099% of Tabula Rasa HealthCare shares are held by insiders and 70.699% by institutions.
How many people work for Tabula Rasa HealthCare?
Latest data suggests 1,027 work at Tabula Rasa HealthCare.
When does the fiscal year end for Tabula Rasa HealthCare?
Tabula Rasa HealthCare's fiscal year ends in December.
Where is Tabula Rasa HealthCare based?
Tabula Rasa HealthCare's address is: 228 Strawbridge Drive, Moorestown, NJ, United States, 08057
What is Tabula Rasa HealthCare's ISIN number?
Tabula Rasa HealthCare's international securities identification number is: US8733791011
What is Tabula Rasa HealthCare's CUSIP number?
Tabula Rasa HealthCare's Committee on Uniform Securities Identification Procedures number is: 873379101

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site